-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Champions Oncology, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2024.
- Champions Oncology, Inc. Return On Equity for the quarter ending July 31, 2025 was 87.9 %, a 72.8% decline year-over-year.
- Champions Oncology, Inc. annual Return On Equity for 2024 was -957 %, a 882% decline from 2023.
- Champions Oncology, Inc. annual Return On Equity for 2023 was -97.5 %, a 55% decline from 2022.
- Champions Oncology, Inc. annual Return On Equity for 2022 was -62.9 %, a 901% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)